Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Keita Masuzawa, M.D., Ph.D.

Concepts (119)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Foramen Ovale, Patent120162140.430 Why?
Lung Neoplasms132022132490.390 Why?
Aniline Compounds4202010680.380 Why?
Carcinoma, Non-Small-Cell Lung9202052480.370 Why?
Acrylamides420202600.360 Why?
Fibroblast Growth Factor 912021130.200 Why?
Lung Diseases, Interstitial220229070.200 Why?
Protein Kinase Inhibitors4202056400.170 Why?
GTPase-Activating Proteins120224750.160 Why?
Drug Resistance, Neoplasm5202052300.160 Why?
Guanine Nucleotide Exchange Factors120225680.160 Why?
Receptors, Antigen, T-Cell, gamma-delta120203450.160 Why?
Genes, erbB-1120191600.160 Why?
Insulin-Like Growth Factor II120202680.150 Why?
Signal Recognition Particle12018470.150 Why?
Japan4202413690.150 Why?
Receptor, IGF Type 1120203800.150 Why?
Neoplasms, Multiple Primary120215860.140 Why?
Dyspnea3202413520.140 Why?
Small Cell Lung Carcinoma120214210.130 Why?
Pyrrolidines120183380.130 Why?
Septal Occluder Device120161260.120 Why?
Pneumonia2202221380.120 Why?
Muscular Diseases120185520.110 Why?
Genome-Wide Association Study22022126020.110 Why?
Proto-Oncogene Proteins p21(ras)1202017290.110 Why?
Mutation52020299510.100 Why?
Reactive Oxygen Species1202021360.100 Why?
Pyrazines1201812020.100 Why?
Idiopathic Pulmonary Fibrosis120174990.100 Why?
Piperazines2202025200.090 Why?
Xenograft Model Antitumor Assays4202035840.090 Why?
Sulfonamides1202019730.090 Why?
Mice, Inbred BALB C4202162210.090 Why?
Intracellular Signaling Peptides and Proteins1202028740.090 Why?
Antineoplastic Agents42020136290.080 Why?
Indoles1201718300.080 Why?
Piperidines1201816500.080 Why?
Carcinoma, Hepatocellular1202123000.080 Why?
Arthritis, Rheumatoid1202237630.070 Why?
Mice, Inbred NOD2202118370.070 Why?
Cell Line, Tumor52020169080.070 Why?
Mice, SCID2202126270.060 Why?
Liver Neoplasms1202143200.060 Why?
Drug Synergism2201917550.060 Why?
Antineoplastic Combined Chemotherapy Protocols32021117080.060 Why?
Mesocricetus120222520.050 Why?
Prednisolone120223280.050 Why?
Humans2120247602760.050 Why?
Aged, 80 and over42022589530.050 Why?
Cell Transdifferentiation120211850.040 Why?
Cough120245950.040 Why?
Intracellular Space120201970.040 Why?
Lectins, C-Type120225910.040 Why?
Alleles2202269000.040 Why?
Interferon Type I120225590.040 Why?
Carboplatin120217890.040 Why?
Sequence Homology120181950.040 Why?
Female1020243910240.040 Why?
Quality of Life32024133010.040 Why?
Cluster Analysis1202426980.030 Why?
Pyrimidines2202030110.030 Why?
Fatigue1202415440.030 Why?
Multicenter Studies as Topic1202117230.030 Why?
Molecular Dynamics Simulation120194340.030 Why?
Receptors, Immunologic1202214340.030 Why?
Mice52021812120.030 Why?
Receptor Protein-Tyrosine Kinases1202216140.030 Why?
Oncogenes1202012210.030 Why?
Oxidation-Reduction1202022220.030 Why?
Quantitative Trait Loci1202221010.030 Why?
Protein Multimerization120199830.030 Why?
Gene Silencing1202015110.030 Why?
Animals620221679350.030 Why?
Prospective Studies32024542650.030 Why?
Paclitaxel1202117380.030 Why?
Immunoglobulins, Intravenous120186640.030 Why?
Viral Load1202233230.030 Why?
Apoptosis2202094970.030 Why?
Lung2202299880.030 Why?
Fatal Outcome1201718330.030 Why?
Disease Progression22021135030.030 Why?
Exons1201823910.030 Why?
Oncogene Proteins, Fusion1202015910.030 Why?
Disease Models, Animal22022181350.030 Why?
Random Allocation1201723930.030 Why?
Gene Amplification1201710850.030 Why?
Up-Regulation1202141270.020 Why?
Epithelial-Mesenchymal Transition120177300.020 Why?
Pyrazoles1202219920.020 Why?
Membrane Glycoproteins1202237310.020 Why?
RNA, Small Interfering1202034420.020 Why?
Weight Loss1202226830.020 Why?
Aged520241690020.020 Why?
Tumor Cells, Cultured1201861310.020 Why?
Protein Conformation1201839690.020 Why?
Protein-Tyrosine Kinases1201924150.020 Why?
Drug Therapy, Combination1201964990.020 Why?
Pyridines1202028770.020 Why?
Phosphorylation1202083140.020 Why?
Glucocorticoids1201721430.020 Why?
Dose-Response Relationship, Drug12020108280.020 Why?
Macrophages1202257460.020 Why?
Middle Aged420232201790.020 Why?
Amino Acid Sequence12018134560.020 Why?
Immunosuppressive Agents1201841680.020 Why?
Adult320242198430.010 Why?
Inflammation12022107580.010 Why?
Polymorphism, Single Nucleotide12022157650.010 Why?
Cell Proliferation12018104390.010 Why?
Adenocarcinoma1201963100.010 Why?
Male420213594270.010 Why?
Genetic Predisposition to Disease12022177660.010 Why?
Cohort Studies12021413160.010 Why?
Signal Transduction12020233660.010 Why?
Adolescent12024877490.010 Why?
Tomography, X-Ray Computed12017204830.010 Why?
Treatment Outcome12019649680.010 Why?
Magnetic Resonance Imaging12018362300.010 Why?
Masuzawa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (119)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.